News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
100,697 Results
Type
Article (5718)
Company Profile (11)
Press Release (94968)
Multimedia
Podcasts (15)
Webinars (5)
Section
Business (39305)
Career Advice (359)
Deals (7038)
Drug Delivery (17)
Drug Development (8627)
Employer Resources (29)
FDA (1430)
Job Trends (1759)
News (55859)
Policy (3901)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Standard (1)
Academia (259)
Accelerated approval (6)
Adcomms (1)
Allergies (18)
Alliances (5318)
ALS (22)
Alzheimer's disease (174)
Antibody-drug conjugate (ADC) (61)
Approvals (1444)
Artificial intelligence (70)
Autoimmune disease (30)
Automation (6)
Bankruptcy (65)
Best Places to Work (1428)
BIOSECURE Act (2)
Biosimilars (36)
Biotechnology (13)
Bladder cancer (9)
Brain cancer (5)
Breast cancer (81)
Cancer (550)
Cardiovascular disease (25)
Career advice (321)
Career pathing (4)
CAR-T (38)
CDC (8)
Cell therapy (108)
Cervical cancer (3)
Clinical research (7344)
Collaboration (234)
Company closure (1)
Compensation (53)
Complete response letters (9)
COVID-19 (337)
CRISPR (5)
C-suite (345)
Cystic fibrosis (28)
Data (658)
Denatured (2)
Depression (18)
Diabetes (76)
Diagnostics (825)
Digital health (9)
Diversity, equity & inclusion (10)
Drug discovery (44)
Drug pricing (21)
Drug shortages (5)
Duchenne muscular dystrophy (71)
Earnings (17640)
Editorial (17)
Employer branding (1)
Employer resources (27)
Events (11263)
Executive appointments (423)
FDA (1844)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Funding (254)
Gene editing (22)
Generative AI (5)
Gene therapy (100)
GLP-1 (143)
Government (571)
Grass and pollen (1)
Guidances (79)
Healthcare (2924)
HIV (4)
Huntington's disease (7)
IgA nephropathy (16)
Immunology and inflammation (36)
Immuno-oncology (12)
Indications (11)
Infectious disease (379)
Inflammatory bowel disease (37)
Inflation Reduction Act (1)
Influenza (17)
Intellectual property (56)
Interviews (44)
IPO (3039)
IRA (8)
Job creations (345)
Job search strategy (277)
JPM (4)
Kidney cancer (3)
Labor market (13)
Layoffs (70)
Leadership (7)
Legal (1031)
Liver cancer (8)
Longevity (3)
Lung cancer (74)
Lymphoma (27)
Machine learning (6)
Management (7)
Manufacturing (109)
MASH (34)
Medical device (2105)
Medtech (2121)
Mergers & acquisitions (4310)
Metabolic disorders (180)
Multiple sclerosis (19)
NASH (3)
Neurodegenerative disease (40)
Neuropsychiatric disorders (16)
Neuroscience (351)
NextGen: Class of 2026 (941)
Non-profit (418)
Now hiring (4)
Obesity (75)
Opinion (67)
Ovarian cancer (26)
Pain (36)
Pancreatic cancer (19)
Parkinson's disease (36)
Partnered (2)
Patents (88)
Patient recruitment (64)
Peanut (6)
People (17104)
Pharmaceutical (10)
Pharmacy benefit managers (6)
Phase 1 (2343)
Phase 2 (3433)
Phase 3 (2531)
Pipeline (876)
Policy (46)
Postmarket research (158)
Preclinical (850)
Press Release (17)
Prostate cancer (23)
Psychedelics (9)
Radiopharmaceuticals (70)
Rare diseases (130)
Real estate (536)
Recruiting (15)
Regulatory (2918)
Reports (15)
Research institute (289)
Resumes & cover letters (44)
Rett syndrome (3)
RNA editing (1)
RSV (8)
Schizophrenia (41)
Series A (58)
Series B (28)
Service/supplier (1)
Sickle cell disease (11)
Special edition (3)
Spinal muscular atrophy (19)
Sponsored (9)
Startups (549)
State (1)
Stomach cancer (1)
Supply chain (19)
Tariffs (7)
The Weekly (13)
Vaccines (123)
Venture capital (18)
Weight loss (46)
Women's health (11)
Worklife (2)
Date
Today (6)
Last 7 days (83)
Last 30 days (330)
Last 365 days (4804)
2026 (478)
2025 (4890)
2024 (6019)
2023 (6517)
2022 (9019)
2021 (9203)
2020 (8302)
2019 (6448)
2018 (5074)
2017 (4765)
2016 (4458)
2015 (5159)
2014 (3859)
2013 (2912)
2012 (3151)
2011 (3288)
2010 (2945)
Location
Africa (106)
Alabama (13)
Alaska (2)
Arizona (47)
Arkansas (4)
Asia (6828)
Australia (974)
California (1614)
Canada (663)
China (206)
Colorado (100)
Connecticut (85)
Delaware (48)
Europe (14386)
Florida (277)
Georgia (61)
Idaho (6)
Illinois (132)
India (7)
Indiana (107)
Japan (89)
Kansas (11)
Kentucky (3)
Louisiana (2)
Maine (7)
Maryland (251)
Massachusetts (1105)
Michigan (30)
Minnesota (70)
Missouri (12)
Montana (13)
Nebraska (6)
Nevada (16)
New Hampshire (21)
New Jersey (667)
New Mexico (7)
New York (414)
North Carolina (275)
Northern California (793)
Ohio (47)
Oklahoma (4)
Oregon (2)
Pennsylvania (314)
Puerto Rico (9)
Rhode Island (8)
South America (173)
South Carolina (4)
Southern California (623)
Tennessee (16)
Texas (277)
United States (5989)
Utah (38)
Virginia (20)
Washington D.C. (9)
Washington State (78)
West Virginia (1)
Wisconsin (15)
Wyoming (1)
100,697 Results for "miraca holding".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Gene editing
FDA Lifts One of Two Clinical Holds on Intellia’s ATTR Gene Editing Program
After a patient safety signal and then death, the FDA in October 2025 placed holds on two of the company’s CRISPR programs for hereditary transthyretin amyloidosis.
January 27, 2026
·
2 min read
·
Dan Samorodnitsky
ADCs
Lung Cancer Trial to Proceed After FDA Releases Hold on Merck, Daiichi’s ADC
The FDA initially placed the Phase III IDeate-Lung02 study on hold due to a “higher than expected” number of deaths in patients treated with ifinatamab deruxtecan.
January 13, 2026
·
3 min read
·
Tristan Manalac
Press Releases
Cellbxhealth PLC Announces Holding(s) in Company
December 23, 2025
·
2 min read
Press Releases
Faron Pharmaceuticals Ltd: Holding(s) in Company
December 5, 2025
·
3 min read
Opinion
2025 Reshaped the FDA. What Will 2026 Hold?
The FDA underwent significant changes during the first year of the second Trump administration, directly affecting business risk and opportunity. Understanding key 2025 trends will be critical to developing regulatory strategies and maximizing opportunities for success.
February 9, 2026
·
6 min read
·
Claire Davies
Press Releases
Scilex Holding Company Announces $20 Million Strategic Investment in Quantum Scan Holdings, Inc., Targeting Trillion-Dollar Preventive Diagnosis and Prognosis Markets
February 1, 2026
·
8 min read
Press Releases
Imbed Biosciences Secures Strategic Investment from BioLab Holdings
February 4, 2026
·
2 min read
Press Releases
EXACT Therapeutics: Exercise of Warrants by GE Medical Holding AB
February 5, 2026
·
2 min read
Press Releases
LakeShore Biopharma to Hold Extraordinary General Meeting of Shareholders
January 20, 2026
·
6 min read
ALS
FDA Lifts Clinical Hold, Clearing Neurizon’s ALS Drug for Human Trials
The hold was placed earlier this year when the FDA asked for more preclinical data, but the agency was slow to respond due to ‘strain’ on its capacity, according to Neurizon.
October 6, 2025
·
2 min read
·
Dan Samorodnitsky
1 of 10,070
Next
